TAZTIA XT Detail

Drug Name(s):
TAZTIA XT

FDA Application No.:
NDA 075401

Active Ingredient(s):
DILTIAZEM HYDROCHLORIDE

Company:
ANDRX PHARMS

Original Approval or Tentative Approval Date:
April 9, 2003

Products on Application NDA 075401:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
DILTIAZEM HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE; ORAL	Prescription	AB4
DILTIAZEM HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE; ORAL	Prescription	AB4
DILTIAZEM HYDROCHLORIDE	360MG	CAPSULE, EXTENDED RELEASE; ORAL	Prescription	AB4

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	December 2008
S	M	T	W	T	F	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Job search

Find jobs in healthcare or try morejob search engines.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

We comply with the HONcode standard for health trust worthy information:
verify here.

Links to Site

last updated on 12-05-2008

TAZTIA XT Detail

Hot Topics

Sponsored Links

Recall Notices

Action Alerts

Most Recent Content

Active forum topics

Poll

Subscribe to our feed